Federica R Achini-Gutzwiller (Federica Achini-Gutzwiller)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

High Throughput

Top Venues

Therapeutic drug monitoring

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Federica R Achini-Gutzwiller, Marco W Schilham, Erik Gabriël Jacques von Asmuth, Anja Jansen-Hoogendijk, Cornelia M Jol-van der Zijde, Maarten J D van Tol, Robbert G M Bredius, Tayfun Güngör, Arjan C Lankester, Dirk Jan Moes
Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study. Blood advances (2023)
Federica R Achini-Gutzwiller, Cornelia M Jol-van der Zijde, Anja M Jansen-Hoogendijk, Arjan C Lankester, Robbert G M Bredius, Maarten J D van Tol, Dirk Jan A R Moes, Marco W Schilham
Development and Validation of an Efficient and Highly Sensitive ELISA for Alemtuzumab Quantification in Human Serum and Plasma. Therapeutic drug monitoring (2022)
Federica R Achini-Gutzwiller, John A Snowden, Selim Corbacioglu, Raffaella Greco, null null
Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation. British journal of haematology 198 (1) (2022)